Proteolytic Cleavage of Chromogranin A (CgA) by Plasmin
Chromogranin A (CgA), the major soluble protein in catecholamine storage vesicles, serves as a prohormone that is cleaved into bioactive peptides that inhibit catecholamine release, providing an autocrine, negative feedback mechanism for regulating catecholamine responses during stress. However, the...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2001-01, Vol.276 (27), p.25022-25029 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Chromogranin A (CgA), the major soluble protein in catecholamine storage vesicles, serves as a prohormone that is cleaved
into bioactive peptides that inhibit catecholamine release, providing an autocrine, negative feedback mechanism for regulating
catecholamine responses during stress. However, the proteases responsible for the processing of CgA and release of bioactive
peptides have not been established. Recently, we found that chromaffin cells express components of the plasmin(ogen) system,
including tissue plasminogen activator, which is targeted to catecholamine storage vesicles and released with CgA and catecholamines
in response to sympathoadrenal stimulation, and high affinity cell surface receptors for plasminogen, to promote plasminogen
activation at the cell surface. In the present study, we investigated processing of CgA by plasmin and sought to identify
specific bioactive CgA peptides produced by plasmin proteolysis. Highly purified human CgA (hCgA) was produced by expression
in Escherichia coli and purification using metal affinity chromatography. hCgA was digested with plasmin. Matrix-assisted laser desorption/ionization
mass spectrometry identified a major peptide produced with a mass/charge ratio ( m / z ) of 1546, corresponding uniquely to hCgA-(360â373), the identity of which was confirmed by reverse phase high pressure liquid
chromatography and amino-terminal microsequencing. hCgA-(360â373) was selectively liberated by plasmin from hCgA at early
time points and was stable even after prolonged exposure to plasmin. The corresponding synthetic peptide markedly inhibited
nicotine-induced catecholamine release from pheochromocytoma cells. These results identify plasmin as a protease, present
in the local environment of the chromaffin cell, that selectively cleaves CgA to generate a bioactive fragment, hCgA-(360â373),
that inhibits nicotinic-mediated catecholamine release. These results suggest that the plasminogen/plasmin system through
its interaction with CgA may play a major role in catecholaminergic function and suggest a specific mechanism as well as a
discrete CgA peptide through which this effect is mediated. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M101545200 |